PALI Live signals | Maximize Profits with Getagraph.com

BUY 104720 min ago

@ $0.419

Issued: 13 Feb 2024 @ 10:41

Return: 1 387.23%

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 16:00):

Stats
Today's Volume	70 139.00
Average Volume	1.08M
Market Cap	75.57M
EPS	$0 ( 2024-03-27 )
Next earnings date	( $-4.80 ) 2024-05-10
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	19.47
ATR14	$0.0530 (0.86%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-11	Finley John David	Buy	5 558	Common Stock, par value $0.01
2024-03-11	Finley John David	Sell	5 558	Restricted Stock Units
2024-02-09	Neal James R	Buy	12 160	Common Stock Options
2024-02-09	Neal James R	Buy	5 820	Common Stock, par value $0.01
2024-02-09	Neal James R	Buy	6 880	Common Stock Options

INSIDER POWER
33.99
Last 100 transactions
Buy: 569 716 \| Sell: 281 847

Volume Correlation

Long: -0.04 (neutral)

Short: -0.92 (very strong negative)

Signal:(43.835) Neutral

Palisade Bio, Inc. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Palisade Bio, Inc. Correlation - Currency/Commodity

-0.32
( neutral )

-0.48
( neutral )

0.00
( neutral )

0.24
( neutral )

0.06
( neutral )

0.75
( moderate )

Palisade Bio, Inc. Financials

Annual	2022
Revenue:	$0
Gross Profit:	$-167 000 (0.00 %)
EPS:	$-14.54

FY	2022
Revenue:	$0
Gross Profit:	$-167 000 (0.00 %)
EPS:	$-14.54

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-109.92

FY	2020
Revenue:	$13 520.00
Gross Profit:	$13 520.00 (100.00 %)
EPS:	$-293.16

Financial Reports:

No articles found.

Palisade Bio, Inc.

Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing oral therapies that target serious diseases associated with the breakdown of the mucosal barrier protecting the gastrointestinal tract. Its lead therapeutic candidate is LB1148, an oral liquid formulation of the digestive enzyme inhibitor that is intended to inhibit digestive enzyme activity and preserve gut integrity during intestinal stress resulting from reduced blood flow to the intestine, infections, or due to surgery. The company was founded in 2005 and is headquartered in Carlsbad, California.